MYOD1 and gastric cancer: Zhao et al. found that MeCP2 promotes gastric cancer cell proliferation via the FOXF1-mediated Wnt5a/β-Catenin pathway and suppresses apoptosis through the MYOD1-mediated Caspase-3 pathway [30].